ArticleCancer medicine2023

Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer.

Hye Sook Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.